Adam Truby

Alexandra J Spencer 3 collaborations

Marta Ulaszewska 2 collaborations

Elizabeth R Allen 2 collaborations

Sarah C Gilbert 2 collaborations

Teresa Lambe 2 collaborations

Paul F McKay 1 collaboration

Sandra Belij-Rammerstorfer 1 collaboration

Cameron D Bissett 1 collaboration

Kai Hu 1 collaboration

Karnyart Samnuan 1 collaboration

Anna K Blakney 1 collaboration

Daniel Wright 1 collaboration

Hannah R Sharpe 1 collaboration

Ciaran Gilbride 1 collaboration

Robin J Shattock 1 collaboration

Susan Morris 1 collaboration

Claire Powers 1 collaboration

Reshma Kailath 1 collaboration

Cameron Bissett 1 collaboration

Nazia Thakur 1 collaboration

Joseph Newman 1 collaboration

Indra Rudiansyah 1 collaboration

Chang Liu 1 collaboration

Wanwisa Dejnirattisai 1 collaboration

Juthathip Mongkolsapaya 1 collaboration

Hannah Davies 1 collaboration

Francesca R Donnellan 1 collaboration

David Pulido 1 collaboration

Thomas P Peacock 1 collaboration

Wendy S Barclay 1 collaboration

Helen Bright 1 collaboration

Kuishu Ren 1 collaboration

Gavin Screaton 1 collaboration

Patrick McTamney 1 collaboration

Dalan Bailey 1 collaboration

Xiangmin Lv 1 collaboration

Jesse Martin 1 collaboration

Heather Hoover 1 collaboration

Bishnu Joshi 1 collaboration

Margaret Wilkens 1 collaboration

David A Ullisch 1 collaboration

Thomas Leibold 1 collaboration

John S Juchum 1 collaboration

Sanket Revadkar 1 collaboration

Barbara Kalinovska 1 collaboration

Justin Keith 1 collaboration

Gui Liu 1 collaboration

Elaine Sun 1 collaboration

John Haserick 1 collaboration

Jon DeGnore 1 collaboration

Joseph Conolly 1 collaboration

Adrian V S Hill 1 collaboration

John Baldoni 1 collaboration

Charlotte Kensil 1 collaboration

Dan Levey 1 collaboration

Gilbert Gorr 1 collaboration

Mark Findeis 1 collaboration

Antoine Tanne 1 collaboration

Affiliations

Publications (3)

Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice.

The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies.

Chemical and biological characterization of vaccine adjuvant QS-21 produced via plant cell culture.

Réseau de co-auteurs